TrialFrontiers in immunology

High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China.

Wei Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.